Gastroenterology CME

This site offers numerous brief presentations concerning Hepatitis B (HBV), Hepatitis C (HBC), Hepatic Encephalopathy (HE) and Hepatocellular Carcinoma (HCC).

Target Audiences:
Hepatology, Gastroenterology and any medical professional who serves patients with chronic liver disease.

About 17 text-based or case-based-interactive activities concerned with aspects of Hepatitis B and Hepatitis C infection.

All of these categories offer CME credit: Conference Coverage, Journal Options, Management Series, Treatment Updates, Annual Updates and Interactive Cases.

Recent presentations include:
• Highlights From Amsterdam 2013: HCV Phase III Studies and Approved Agents
• Management of Chronic Hepatitis B Virus Infection in Women of Reproductive Age
• Hepatitis Highlights
• So You Think You’re a Hepatitis C Expert, Educational Material, Part 3
• Updates in Viral Hepatitis from AASLD 2012
• Treat or Wait in HCV? A Series of Challenging Case Vignettes

Target Audience: Physicians focusing on Infectious Disease and related specialties.

The goal of the Gi Health Foundation is to provide health professionals with the most current education and information on gastrointestinal health.

Major areas of focus are: Irritable Bowel Syndrome; Inflammatory Bowel Disease; Crohn’s Disease; Ulcerative Colitis; and Fecal Incontinence.

Some recent topics include:
• The Great Debates in Functional GI Disorders: Discussing the Clinical Implications of Fecal Incontinence and IBS
• Xpert Perspectives from UEGW… Reporting on IBS
• Xpert Perspectives from ACG… Reporting on IBS
• Management of Irritable Bowel Syndrome With Constipation (IBS-C): From Conventional to New and Emerging Pharmacologic Therapies

Target Audience: Physicians specializing in Gastroenterology, Internal Medicine, and Family Medicine

A set of brief (30 minutes) case simulations about:
• Hepatitis A (3)
• Hepatitis B (14)
• Hepatitis C (6)
• Common Management Issues (2) and
• Health Educator (2).

Target Audience: Physicians focusing on Family Medicine, Internal Medicine, and Infectious Disease

Only the webcasts offer CME credit. Of these, 13 are in Oncology; other areas are Hematology (7) and Gastroenterology (6). Many of the webcasts offer multiple modules.

Target Audiences:
Physicians specializing in Hematology, Oncology, or Gastroenterology.

CME activities of special interest to gastroenterologists.

Medscape contains a variety of educational formats:

CONFERENCE COVERAGE – Reports of advances presented at major medical conferences; typically includes several tracks with news stories, expert interviews, and in-depth topic overviews.

CLINICAL UPDATE – Comprehensive original review article on scientific advances in a clinical topic.

FAST TRACK CLINICAL UPDATE – Narrowly focused original review article on scientific advances in a clinical topic.

CME-LIVE – Real-time online events with streaming video, synchronized visuals, and interactive questions and answers; archived for 1 year.

CLINICAL BRIEFS – Daily reports of major current medical research articles; 0.25 credits each

JOURNAL CME – Articles selected from a wide selection of peer-reviewed journals.

SPECIAL REPORT CME – Topic-based monthly email newsletter distributed to Medscape’s professional member database by specialty.

INTERACTIVE PATIENT CASES – Original CME activity presented to the physician in an interactive, clinical case-based format. (See especially eMedicine CME Case Presentations.)

CME CIRCLE – Multimedia content certified by other accredited professional education providers, typically from live symposia or monographs, and then posted on Medscape and archived for one year.

Target Audience: Gastroenterologists

Discover New Guidelines with Pathology CME

Gastropathology is an online CME course that combines traditional lectures and microscopy sessions to review recent concepts in esophagitis, gastritis, and dysplasia, as well as discussions of the small intestine, colon, and anus.

In addition to discussions on difficult and rapidly evolving areas in pathology, sessions in this continuing medical education program — part of our Masters of Pathology Series — address topics that will help you:

• Understand liver neoplasms and medical liver
• Define gastrointestinal and liver mesenchymal tumors
• Assess inflammatory esophagus biopsies, especially those with lymphocytosis
• Evaluate hepatic adenomas
• Recognize clues for separating reactive and neoplastic changes in esophageal and gastric samples

Learning Objectives

After viewing this program, the participant will be better able to:

• Discuss the significance of esophageal lymphocytosis
• Use diagnostic clues to separate reactive and dysplastic changes in columnar biopsies from the esophagus and stomach
• Describe the features of autoimmune hepatitis and its differential diagnosis
• Recognize the key types of gastritis
• Describe several types of gastric polyps
• Discuss non-neoplastic small intestinal pathology
• Define HPV-associated anal neoplasms
• Understand the classification of hepatic neoplasms
• Recognize key GI tract mesenchymal neoplasms
• Describe key features of appendiceal neoplasms

Intended Audience

This educational activity was designed for pathologists and gastroenterologists in practice, pathology residents, and gastroenterology fellows.

Earn CME Credits and Board Review Prep

The Brigham Board Review in Gastroenterology and Hepatology provides in-depth CME coverage of wide-ranging topics, keeping you abreast of the latest advances in the field.

This board review course includes case-based lectures on topics like GERD, gastrointestinal bleeding, gastric and small bowel motility disorders, acute liver failure, celiac disease, benign and malignant biliary diseases, and more. It’s online CME that will help you to better:

• Apply latest/recommended gastroenterology guidelines in clinical practice
• Attain the latest knowledge on clinical presentation, pathologic features, diagnosis, and differential diagnosis of various gastroenterology disorders
• Stay updated on an expanding array of therapeutic options for diverse gastrohepatic disorders
• Evaluate and interpret up-to-date literature for evidence-based clinical practice in gastroenterology
• Prepare for ABIM certification/recertification gastroenterology examinations

Learning Objectives

At the conclusion of this activity, the participant will be able to:

• Apply current/recommended gastroenterology guidelines in clinical practice
• Perform differential diagnosis of complex clinical presentations related to gastroenterology disorders
• Identify and apply current therapeutic options for specific gastroenterology disorders
• Analyze and interpret up-to-date literature relevant to clinical practice in gastroenterology
• Recognize and apply knowledge of pathophysiology as it applies to management of gastroenterology disorders
• Apply knowledge gained to the ABIM certification/recertification gastroenterology examinations

Intended Audience

This educational activity was designed for fellows/trainees and practicing gastroenterology specialists (MDs) and other professional affiliates (internists with an interest in gastroenterology) who are preparing to take ABIM Board Review or Recertification Examinations or who seek CME activities to improve patient care in the area of gastroenterology medicine. The target audience is regional, national and international.

Activity Description / Statement of Need:

In this online, self-learning activity:

Non-alcoholic steatohepatitis (NASH) is a form of non-alcoholic fatty liver disease (NAFLD) characterized by steatosis, with the accumulation of fat in the liver in excess of five percent of the liver’s weight, together with hepatic inflammation in the presence or absence of fibrosis. Risk factors for NASH include a number of comorbid metabolic diseases and disorders, including metabolic syndrome, obesity, type 2 diabetes, hypertension, and dyslipidemia. The prevalence of NASH is estimated to be 1.5%-6.45% of the U.S. population, and prevalence of NASH among NAFLD patients to be 59.1% globally.

Target Audience:

The following HCPs in: Gastroenterology, hepatology, and endocrinology; physician assistants, nurse practitioners, and pharmacists who practice in the aforementioned areas of specialty; and those who otherwise have an interest in or commonly care for or clinically encounter patients with NAFLD.

Activity Description / Statement of Need:

In this online, self-learning activity:

Irritable bowel syndrome (IBS) is among the most common disorders seen by primary care as well as gastroenterology specialty clinics. Patients with IBS usually present with chronic abdominal pain and altered bowel habit, in the absence of any other disease to cause these sorts of symptoms. While the precise pathophysiology is still an area of active investigation, it appears to include a neuro-enteric disconnect, leading to intestinal somato-visceral and motor dysfunction. Genetic, immune function, microbiome, psychological, and environmental factors may also predispose patients to develop of IBS. Its prevalence varies according to country and the criteria used to define it. In North America and Europe, it has a 10-15% prevalence, and it varies by country. In the U.S. and Canada, IBS symptoms are 1.5 to 2 times more prevalent among women. Women commonly report abdominal pain and constipation while men report diarrhea. The disorder is associated with annual healthcare expenditures of $20 billion and significant costs in lost work productivity and health-related quality-of-life. 

Target Audience:

The following HCPs: Gastroenterologists and primary care physicians; physician assistants, nurse practitioners, and pharmacists who practice in gastroenterology and internal medicine; and any other HCPs with an interest in or who clinically encounter patients with IBS-C.